ROSSARINSERossari Biotech LimitedLowNeutral
Announced Mon, 21 Jul · 18:57 IST

Audio recording of Earnings Conference call for Q1 FY 26.

Investor Communications View source PDF

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Rossari Biotech has informed the stock exchanges that the audio recording of its Q1 FY26 earnings conference call with analysts and investors, held on July 21, 2025, is now available on the company's website under the 'Investor Call' section. This is a routine regulatory disclosure under SEBI Listing Regulations, following up on an earlier intimation dated July 14, 2025. The filing itself does not contain any financial details or management commentary. Investors who want to hear the management's discussion on Q1 FY26 results can listen to the recording via the company's website.

Likely market impact

This is a procedural disclosure with no direct impact on the stock price or shareholders. Investors seeking insights into Q1 FY26 performance, margins, or guidance should listen to the actual conference call recording.